113 related articles for article (PubMed ID: 38244401)
1. The knockdown of stathmin with si-RNA inhibits invasion of mesothelioma.
Aksoy A; Varoglu A; Onalan EE; Tektemur A; Artas G; Koc M; Cakmak M; Aydin S; Kilic M; Ulas M
Tissue Cell; 2024 Apr; 87():102303. PubMed ID: 38244401
[TBL] [Abstract][Full Text] [Related]
2. siRNA-mediated stathmin1 silencing inhibits proliferation of prostate carcinoma cell line.
Aksoy A; Göktürk S; Etem Önalan E; Tektemur A; Artaş G; Varoğlu A; Koç M
Turk J Biol; 2022; 46(3):239-250. PubMed ID: 37529254
[TBL] [Abstract][Full Text] [Related]
3. STMN1 is Overexpressed in Adrenocortical Carcinoma and Promotes a More Aggressive Phenotype In Vitro.
Aronova A; Min IM; Crowley MJP; Panjwani SJ; Finnerty BM; Scognamiglio T; Liu YF; Whitsett TG; Garg S; Demeure MJ; Elemento O; Zarnegar R; Fahey TJ
Ann Surg Oncol; 2018 Mar; 25(3):792-800. PubMed ID: 29214451
[TBL] [Abstract][Full Text] [Related]
4. Stathmin1 plays oncogenic role and is a target of microRNA-223 in gastric cancer.
Kang W; Tong JH; Chan AW; Lung RW; Chau SL; Wong QW; Wong N; Yu J; Cheng AS; To KF
PLoS One; 2012; 7(3):e33919. PubMed ID: 22470493
[TBL] [Abstract][Full Text] [Related]
5. Stathmin1 overexpression associated with polyploidy, tumor-cell invasion, early recurrence, and poor prognosis in human hepatoma.
Hsieh SY; Huang SF; Yu MC; Yeh TS; Chen TC; Lin YJ; Chang CJ; Sung CM; Lee YL; Hsu CY
Mol Carcinog; 2010 May; 49(5):476-87. PubMed ID: 20232364
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of local injection of lentivirus-delivered stathmin1 and stathmin1 shRNA in human gastric cancer xenograft mouse.
Akhtar J; Wang Z; Yu C; Zhang ZP
J Gastroenterol Hepatol; 2014 Sep; 29(9):1685-91. PubMed ID: 24720379
[TBL] [Abstract][Full Text] [Related]
7. A preliminary study: is fibulin 1 a friend or an enemy that needs to be silenced with siRNAs for mesothelioma?
Aksoy A; Tektemur A; Melek E; Kayfeci M; Uslu MF; Cosar U; Onalan E
Contemp Oncol (Pozn); 2020; 24(4):241-246. PubMed ID: 33531871
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of Stathmin1 expression and epithelial-mesenchymal transition in curatively resected gastric cancer.
Ke B; Guo XF; Li N; Wu LL; Li B; Zhang RP; Liang H
Mol Clin Oncol; 2019 Feb; 10(2):214-222. PubMed ID: 30680197
[TBL] [Abstract][Full Text] [Related]
9. Stathmin 1 plays a role in endometrial decidualisation by regulating hypoxia inducible factor-1α and vascular endothelial growth factor during embryo implantation.
Gou J; Jia J; Feng J; Zhao X; Yi T; Cui T; Li Z
Reprod Fertil Dev; 2017 Aug; 29(8):1530-1537. PubMed ID: 27456758
[TBL] [Abstract][Full Text] [Related]
10. Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma.
Watanabe A; Suzuki H; Yokobori T; Tsukagoshi M; Altan B; Kubo N; Suzuki S; Araki K; Wada S; Kashiwabara K; Hosouchi Y; Kuwano H
Cancer Sci; 2014 Jun; 105(6):690-6. PubMed ID: 24708177
[TBL] [Abstract][Full Text] [Related]
11. MiR-101 inhibits cell proliferation and invasion of pancreatic cancer through targeting STMN1.
Zhu L; Chen Y; Nie K; Xiao Y; Yu H
Cancer Biomark; 2018; 23(2):301-309. PubMed ID: 30198871
[TBL] [Abstract][Full Text] [Related]
12. Decreased stathmin-1 expression inhibits trophoblast proliferation and invasion and is associated with recurrent miscarriage.
Tian FJ; Qin CM; Li XC; Wu F; Liu XR; Xu WM; Lin Y
Am J Pathol; 2015 Oct; 185(10):2709-21. PubMed ID: 26272359
[TBL] [Abstract][Full Text] [Related]
13. Stathmin1 overexpression in hypopharyngeal squamous cell carcinoma: A new promoter in FaDu cell proliferation and migration.
Chen Y; Zhang Q; Ding C; Zhang X; Qiu X; Zhang Z
Int J Oncol; 2017 Jan; 50(1):31-40. PubMed ID: 27878293
[TBL] [Abstract][Full Text] [Related]
14. Loss of miR-223 and JNK Signaling Contribute to Elevated Stathmin in Malignant Pleural Mesothelioma.
Birnie KA; Yip YY; Ng DC; Kirschner MB; Reid G; Prêle CM; Musk AW; Lee YC; Thompson PJ; Mutsaers SE; Badrian B
Mol Cancer Res; 2015 Jul; 13(7):1106-18. PubMed ID: 25824152
[TBL] [Abstract][Full Text] [Related]
15. Effects of stathmin 1 silencing by siRNA on sensitivity of esophageal cancer cells Eca-109 to paclitaxel.
Zhu HW; Jiang D; Xie ZY; Zhou MH; Sun DY; Zhao YG
Genet Mol Res; 2015 Dec; 14(4):18695-702. PubMed ID: 26782519
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of stathmin 1 is a poor prognostic biomarker in non-small cell lung cancer.
Nie W; Xu MD; Gan L; Huang H; Xiu Q; Li B
Lab Invest; 2015 Jan; 95(1):56-64. PubMed ID: 25384122
[TBL] [Abstract][Full Text] [Related]
17. Reduced STMN1 expression induced by RNA interference inhibits the bioactivity of pancreatic cancer cell line Panc-1.
Li J; Hu GH; Kong FJ; Wu KM; He B; Song K; Sun WJ
Neoplasma; 2014; 61(2):144-52. PubMed ID: 24299310
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-9 inhibits vasculogenic mimicry of glioma cell lines by suppressing Stathmin expression.
Song Y; Mu L; Han X; Li Q; Dong B; Li H; Liu X
J Neurooncol; 2013 Dec; 115(3):381-90. PubMed ID: 24043603
[TBL] [Abstract][Full Text] [Related]
19. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
[TBL] [Abstract][Full Text] [Related]
20. miR-423-5p Inhibits Osteosarcoma Proliferation and Invasion Through Directly Targeting STMN1.
Wang X; Peng L; Gong X; Zhang X; Sun R; Du J
Cell Physiol Biochem; 2018; 50(6):2249-2259. PubMed ID: 30423576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
